Physician profile
John Golding
NPI 1255307575
$20,895.52
in general payments reported to CMS, 2019-2025
53 companies · $1,161 in 2025
The $1,161 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,855 · 2020: $3,339 · 2021: $2,205 · 2022: $3,508 · 2023: $3,737 · 2024: $4,090 · 2025: $1,161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,957 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,956.52 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $2,239.28 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Abbott Laboratories | $2,195.57 | 2019-2025 | Aveir, Jot Dx, Navitor |
| Medtronic Vascular, INC. | $1,911.18 | 2019-2020 | |
| Medtronic, INC. | $1,901.74 | 2020-2025 | Corevalve Evolut R, Aurora Ev-Icd Mri Surescan, Symplicity G3 |
| Novartis Pharmaceuticals Corporation | $1,792.75 | 2019-2024 | |
| Boston Scientific Corporation | $1,223.17 | 2019-2024 | Watchman Access System, Watchman Flx, Wolverine Coronary Cutting Balloon |
| Janssen Pharmaceuticals, INC | $1,149.13 | 2019-2024 | Xarelto |
| Pfizer INC. | $806.81 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $795.65 | 2019-2024 | Farxiga, Wainua, Brilinta |
| Abiomed | $781.05 | 2020-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $629.84 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $428.18 | 2019-2024 | Repatha |
| Alnylam Pharmaceuticals INC. | $395.41 | 2019-2024 | Amvuttra |
| Penumbra, INC. | $391.29 | 2021-2025 | Indigo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $380.98 | 2020-2024 | Jardiance |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $332.89 | 2019-2024 | (Ck4) Mcot, (Br3) Coronary Other |
| Inari Medical, INC. | $284.52 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Chiesi USA, INC. | $260.49 | 2019-2024 | Cleviprex, Kengreal |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $230.30 | 2019-2024 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $213.96 | 2022-2024 | Opsumit, Uptravi |
| Edwards Lifesciences Corporation | $209.96 | 2020-2021 | |
| Teleflex LLC | $207.93 | 2022-2024 | Turnpike, Vascband, Trapliner |
| Merck Sharp & Dohme LLC | $206.31 | 2021-2023 | Verquvo |
| Novo Nordisk INC | $198.21 | 2024-2025 | Ozempic, Wegovy |
| Zoll Circulation INC | $146.60 | 2022 | |
| Atricure, INC. | $143.65 | 2023 | |
| Vifor Pharma, INC. | $136.08 | 2020 | |
| Astellas Pharma US INC | $127.97 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $126.74 | 2019-2023 | Evkeeza, Praluent |
| Lexicon Pharmaceuticals, INC. | $125.31 | 2023 | Inpefa |
| Amarin Pharma, INC. | $96.58 | 2019-2022 | |
| Daiichi Sankyo INC. | $86.95 | 2021-2024 | Injectafer |
| Azurity Pharmaceuticals, INC. | $78.72 | 2023-2024 | Edarbyclor, Edarbi |
| Kiniksa Pharmaceuticals, LTD. | $71.34 | 2023 | Arcalyst |
| Lundbeck LLC | $59.51 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $55.18 | 2019 | |
| Lantheus Medical Imaging, INC. | $49.07 | 2021-2024 | |
| Esperion Therapeutics, INC. | $46.37 | 2020 | |
| Cardiva Medical, INC. | $40.91 | 2022 | |
| Arbor Pharmaceuticals, INC. | $39.88 | 2019-2022 | |
| Osprey Medical INC | $37.02 | 2020 | |
| Biotronik INC. | $34.09 | 2019-2020 | |
| Scpharmaceuticals INC. | $30.64 | 2023-2024 | |
| Vital Connect, INC | $26.26 | 2024 | Vitalpatch Rtm |
| Kowa Pharmaceuticals America, INC. | $24.89 | 2020-2021 | |
| Cordis US Corp. | $22.08 | 2023 | Zephyr |
| Akcea Therapeutics, INC. | $21.94 | 2020 | |
| Terumo Medical Corporation | $20.93 | 2024 | Tr Band |
| Kiniksa Pharmaceuticals International, Plc | $19.08 | 2024 | Arcalyst |
| Gilead Sciences, INC. | $18.11 | 2019 | |
| Asahi Intecc USA, INC. | $15.69 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.22 | 2022 | |
| Portola Pharmaceuticals, LLC | $13.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Golding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.